Table 3. Summary of univariate and multivariate Cox regression analysis of overall survival duration in cervical cancer patients.
Parameter | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
P | HR | 95% CI | P | HR | 95% CI | |
Age (years) | 0.490 | 0.838 | 0.507–1.385 | 0.153 | 0.663 | 0.377–1.165 |
(≤50 compared with >50) | ||||||
Clinical stage | <0.001 | 2.645 | 1.546–4.526 | 0.289 | 1.557 | 0.687–3.528 |
(I-IIA vs. IIB-IV) | ||||||
Tumor size (cm) | 0.237 | 1.356 | 0.819–2.247 | 0.303 | 1.342 | 0.767–2.349 |
(≤4 compared with >4) | ||||||
Lymph node metastasis | <0.001 | 3.221 | 1.839–5.639 | 0.031 | 2.452 | 1.084–5.546 |
(Absent compared withpresent) | ||||||
Distant metastasis | <0.001 | 5.217 | 2.108–12.910 | 0.153 | 2.365 | 0.726–7.700 |
(Absent compared with present) | ||||||
Histological type | <0.001 | 0.331 | 0.179-0.611 | 0.681 | 1.198 | 0.507-2.832 |
(Squamous cell carcinoma compared with adenocarcinoma) | ||||||
Histological grade | 0.003 | 2.209 | 1.313–3.717 | 0.166 | 1.499 | 0.846–2.659 |
(Well compared with moderately/poorly) | ||||||
CXCL8 protein expression | 0.002 | 2.338 | 1.378–3.967 | 0.030 | 1.917 | 1.067–3.445 |
(Low compared with high) |
Abbreviations: HR, hazard ratio; 95% CI, 95% confidence interval.